z-logo
Premium
N6‐isopentenyladenosine: A potential therapeutic agent for a variety of epithelial cancers
Author(s) -
Spinola Monica,
Colombo Francesca,
Falvella F. Stefania,
Dragani Tommaso A.
Publication year - 2007
Publication title -
international journal of cancer
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.475
H-Index - 234
eISSN - 1097-0215
pISSN - 0020-7136
DOI - 10.1002/ijc.22601
Subject(s) - clonogenic assay , leukemia , cancer research , cell culture , biology , nucleoside , cell growth , chemistry , biochemistry , genetics
Isopentenyladenosine (i 6 A) is a product of isopentenyltransferases and, in mammals, occurs either bound to tRNA or as a free nucleoside. Sporadic reports have suggested an anticancer effect of i 6 A, mostly on leukemia cells. The present analysis of 9 human epithelial cancer cell lines derived from different types of malignant tissue revealed complete suppression of clonogenic activity in 8 of the lines after exposure to i 6 A at a concentration of 10 μM. Mechanistic studies showed that i 6 A tumor suppressor activity is associated with inhibition of cell proliferation, a block in DNA synthesis and morphological changes. These results point to i 6 A and to its possible derivatives as a new potential class of wide‐spectrum anticancer agents. © 2007 Wiley‐Liss, Inc.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom